In our study, Fibrinogen and MPO displayed different associations with lung function parameters in COPD patients with and without coexisting metabolic syndrome, with Fibrinogen and MPO levels being significantly negatively correlated with DLCO and FEV1, respectively, only in patients without metabolic syndrome. This evidence concerns the gene MPO and metabolic syndrome.